Treat new convulsions during labour as possible eclampsia: protect breathing, terminate and prevent seizures, control severe hypertension, and plan birth after stabilisation. Previous good health does not exclude pre-eclampsia or eclampsia. Also consider epilepsy, hypoglycaemia, intracranial disease and other causes if the clinical findings suggest them; neither an invented history nor a fabricated urine result is needed to recognise the emergency.
Summon obstetric, anaesthetic and neonatal assistance. Protect the woman from injury, position her safely on her side when feasible, maintain the airway, and assess breathing and oxygen saturation. Do not force an object into her mouth or attempt to suppress a fit by forcefully holding down her limbs. Obtain intravenous access, check blood glucose, and measure blood pressure; assess platelets, renal function, liver tests and proteinuria without delaying essential treatment. Review the fetal condition once maternal resuscitation is under way.
Current first-line anticonvulsant treatment is magnesium sulfate. NICE describes an intravenous loading dose of 4 g over 5–15 minutes, followed by 1 g per hour, with continued treatment for 24 hours after the last fit. Recurrent fits require additional treatment under the emergency protocol. Monitor breathing, tendon reflexes and urine output because impaired renal function increases the risk of magnesium accumulation. A benzodiazepine is not an interchangeable routine substitute for magnesium sulfate in this setting. Severe hypertension requires prompt suitable treatment, for example labetalol, nifedipine or hydralazine, with continuing reassessment.[ref]
Hypertension in pregnancy by NICE. NG133, §§1.8.1–1.8.6: anticonvulsants and immediate treatment of severe hypertension
Once stabilised, the woman needs a plan for birth. Cervical findings, progress of labour, gestation and maternal and fetal condition determine whether vaginal birth or Caesarean section is appropriate. Performing an immediate instrumental delivery during an uncontrolled fit is not a general rule, nor does the occurrence of one fit automatically establish the route of birth. Observation and treatment continue after delivery because further fits in eclampsia can occur.[ref]
Historically, bloodletting, purgation, chloroform and expedited delivery were advocated in different combinations. An actual 1864 case report records such treatment and continuing convulsions despite delivery. It illustrates the historical problem, not proof that removal of blood or pressure on pelvic nerves explains or cures eclampsia.[ref]
Report of a Case of Puerperal Convulsions (1864). pp. 411–413: bloodletting, chloroform, delivery and subsequent course
Modern eclampsia care replaces those obsolete theories with specific seizure treatment, blood-pressure control and maternal resuscitation.Treat scarlet fever as an infectious illness, support fluid and food intake, and distinguish local suppuration, invasive infection and delayed immune complications. The severity of the throat disease and the general condition matter more than the brilliance of the rash.
In 1866, reasonable supportive care meant separation from susceptible contacts, attentive nursing, a comfortable ventilated room, rest and food and fluids that could be swallowed. Severe throat pain, difficulty swallowing, increasing neck swelling, breathing difficulty, marked prostration or altered awareness required repeated examination. Convalescence also needed observation of the urine and swelling. Historical attempts to drive out a rash by excessive heat, aggressive purging or stimulants did not establish a way to remove the cause. Renal complications after apparently successful recovery were already recognized: a contemporary digest discusses delayed albuminuria after the apparent convalescence from scarlet fever.[ref]
Half-yearly abstract of the medical sciences (July–December 1866). Section on albuminuria during convalescence from scarlet fever and other eruptive diseases; report of 29 September 1866
Modern correction: scarlet fever is associated with toxin-producing group A streptococcal infection, and appropriate testing and antibiotic treatment replace supposed rash-specific remedies. A compatible illness may be confirmed by a rapid antigen test, molecular test or throat microbiological culture. Penicillin or amoxicillin is a usual treatment for confirmed disease; allergy and local resistance affect alternatives. Supportive fluid intake and appropriate relief of pain remain useful. Infection-control measures and the applicable exclusion interval after treatment reduce transmission.[ref]
Clinical Guidance for Scarlet Fever by CDC. Testing and diagnosis; Treatment; Prevention
The complications require different responses. Otitis media, cervical lymphadenitis and a peritonsillar abscess or retropharyngeal abscess result from spread of infection. New focal pain or swelling calls for examination; an abscess may require drainage as well as antibiotics. Airway compromise, profound illness or signs of sepsis require urgent hospital care, rather than simply changing a gargle. These complications are distinct from acute rheumatic fever and post-streptococcal glomerulonephritis, which arise through the response to the preceding infection.[ref]
Clinical Guidance for Scarlet Fever by CDC. Complications, suppurative complications and nonsuppurative sequelae
For the renal complication, look for dark or scanty urine, haematuria, oedema and hypertension, including after the throat and rash have improved. Assess kidney function and fluid balance. Treatment addresses hypertension and fluid excess; severe renal complications require specialist management. Antibiotics eradicate persisting group A streptococcal infection and reduce its spread, but are not proved to prevent every case of post-streptococcal glomerulonephritis. When acute rheumatic fever occurs, assess for carditis, treat the inflammatory manifestations and any heart failure, eradicate residual streptococcal infection and arrange appropriate secondary antibiotic prophylaxis. Prevention must not be reduced to waiting for swollen anatomical joints or obvious heart disease.[ref]
Clinical Guidelines for Post-Streptococcal Glomerulonephritis by CDC. Clinical features; Treatment; Prevention, insufficient evidence for antimicrobial prevention of PSGN
[ref]Clinical Guidance for Acute Rheumatic Fever by CDC. Manifestations, subclinical carditis and prevention
Thus “counteracting the complications” means identifying the actual process and its consequences, not applying one remedy to every late symptom.Disappearance of renal oedema is not proof that the kidney disease has resolved. Reassess recovery, make the return to work gradual and address actual exposures and recurrent illness. “Renal dropsy” is a clinical description, not one modern histological diagnosis. It could accompany an acute nephritic illness or persist as part of more chronic disease; the question does not establish which.
A period answer would warn against returning immediately from convalescence to prolonged wet work, chilling, exhaustion and poorly supported living conditions. Dry clothing, suitable warmth, adequate food and rest, avoidance of excess ethanol, and opportunities to change out of wet clothes were practical recommendations. The intended rationale was to reduce strains thought to precipitate another renal attack. This advice should be labelled historical: cold exposure is not a complete modern explanation for glomerulonephritis, and an artisan's occupation does not establish any particular toxic exposure.
The important transferable precaution is continued observation. Re-examine for swelling, breathlessness, changes in urine output, persistent albuminuria and the return of constitutional illness. A nineteenth-century examination could include testing urine for protein and examining its sediment, rather than declaring cure from the appearance of the face or legs. Contemporary reporting of delayed albuminuria after apparent recovery from an eruptive illness illustrates the reason for follow-up, without proving that every later abnormality is a relapse of the same disease.[ref]
Half-yearly abstract of the medical sciences (July–December 1866). Section on delayed albuminuria in convalescence; limitations of apparent clinical recovery
Modern correction: the prevention plan follows the actual renal diagnosis and objective recovery. Assess blood pressure, serum creatinine, estimated glomerular filtration rate and urinary albumin or protein as appropriate, and compare serial results. Some people recover completely from an acute illness; others need surveillance and treatment for persistent chronic kidney disease. Ongoing hypertension, substantial albuminuria or declining renal function requires attention rather than merely warmer clothing. Medicines and supplements should be reviewed for nephrotoxicity, and nonsteroidal anti-inflammatory drugs require particular caution in susceptible people.[ref]
Chronic kidney disease: assessment and management by NICE. NG203, assessment and monitoring; medicines affecting kidney function; blood-pressure control and proteinuria
For work, establish the actual demands: heavy exertion, inability to drink or take breaks, heat, wet conditions and contact with potentially nephrotoxic materials. Adjust duties to the degree of recovery, with occupational assessment where needed. Do not assume a toxin or impose permanent unemployment merely from the word “artisan”. Fluid or salt restrictions and drugs should be individualized to the renal condition; indiscriminate restriction or repeated purging can worsen depletion. The aim is sustainable recovery with follow-up, not a claim that one garment or tonic guarantees against relapse.
Modern hypertrophy means enlargement of individual biological cells; hyperplasia means an increase in their number. Both can enlarge an organ, and both can occur together. The historical question requires care because nineteenth-century authors sometimes included “numerical hypertrophy” within the broader discussion of growth. Rudolf Virchow's 1860 English edition explicitly distinguishes enlargement of existing elements from multiplication of elements, using simple and numerical hypertrophy for these different processes.[ref]
Cellular Pathology by Rudolf Virchow (1860). Lecture III, pp. 93–95, Hypertrophy and Hyperplasy and Degenerative New Formations
At the minute structural level, true hypertrophy entails increased cellular substance and, in a contractile biological cell, more contractile apparatus. Enlarged cell nuclei can accompany it, but a large cell nucleus alone does not prove a proportional increase in functional tissue. Increased cell number belongs to hyperplasia. Apparent organ enlargement from oedema, fatty infiltration, amyloid or a tumour must be distinguished from a coordinated increase of the organ's working tissue.[ref]
Cellular Pathology in Pathology: The Big Picture. Hypertrophy and Hyperplasia; morphological distinction and increased contractile protein in pressure-loaded myocardium
The clearest early-to-late examples compare adaptation with the possible effects of continued overload:
- In the heart, sustained hypertension or aortic stenosis makes the left ventricle work against greater resistance. Initially its cardiomyocytes enlarge and the wall thickens, with enlarged cell nuclei and increased contractile proteins. With prolonged pathological stress there may be fibrosis, loss of cardiomyocytes, ventricular dilatation and heart failure. The late enlarged failing heart need not have a uniformly thick wall; hypertrophy and dilatation describe different structural changes.[ref]Stress Kinase Signaling in Cardiac Myocytes. Cardiac hypertrophy, physiological adaptation versus pathological hypertrophy and progression to heart failure
- In the urinary bladder, persistent outflow obstruction increases the work of the detrusor muscle. Enlargement of smooth muscle bundles thickens the wall and can produce bladder trabeculation. With prolonged obstruction, fibrosis, dilatation and incomplete emptying can coexist with the initial growth. This is a progression possible under sustained pathological load. Human studies describe early hypertrophy and subsequent compensation or decompensation; progression is not an inevitable fate of all enlarged smooth muscle.[ref]Progressive bladder remodeling due to bladder outlet obstruction. Results; Discussion, proposed three-stage model and its evidential limits
- In skeletal muscle, increased use enlarges existing fibres through additional contractile material. Later development of this physiological response produces larger, stronger fibres; it does not inherently require fatty degeneration. If an apparent muscular enlargement is mainly fat or connective tissue, that is pseudohypertrophy.
These illustrations compare different outcomes rather than proposing a universal stage in which every enlarged organ degenerates.[ref]
Hypertrophy and hyperplasia in Underwood's Pathology: a Clinical Approach. Adaptive responses to increased demand; physiological hypertrophy and hyperplasia
[ref]Cellular Pathology in Pathology: The Big Picture. Hypertrophy, physiological and pathological examples
A second set illustrates growth in organs whose biological cells can also divide. The pregnant uterus combines marked enlargement of smooth muscle biological cells with an increase in their number; after delivery it undergoes involution. An enlarged remaining kidney after loss of its partner exemplifies compensatory growth. In a modern rat experiment comparing neonatal, weanling and adult animals after removal of one kidney, the younger groups showed greater compensatory growth; that experimental comparison does not make an age-independent prediction for every human kidney.[ref]
Age-dependent characteristics of compensatory renal growth. Abstract, comparison of neonatal, weanling and young adult rats
Thus organ size alone cannot distinguish the cellular processes: compare cell dimensions, numbers and tissue composition by histology.[ref]Hypertrophy and hyperplasia in Underwood's Pathology: a Clinical Approach. Physiological hypertrophy and hyperplasia, uterine growth; compensatory growth